Pharma

Your Article Summary

See Latest Articles

Antigenics to Raise $10 Million in Private Placement
Antigenics, 08/13/09

Antigenics Inc. announced that it has entered into definitive agreements to sell in a private placement approximately 4.4 million shares of its common stock at a price of $2.28 per share, resulting in gross proceeds to the company of $10 million, before deducting placement agent fees and other offering expenses. The investors in this private placement will also receive six–month warrants to purchase up to approximately 2.2 million additional shares of common stock at an exercise price of $2.31 per share and 4 year warrants to purchase up to approximately 2 million additional shares of common stock at an exercise price of $2.50 per share.

Today in Popular Press...keeping you current

Receive free subspecialty "5-minute updates" via email

Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products
Boehringer Ingelheim, 10/30/09

NIH has awarded $75 million for disparities research
American Hospital Association News, 11/16/09

Medical schools continue to enroll more students, AAMC reports
American Hospital Association News, 11/13/09

See All of Popular Press